General Pharmacology — MCQs

General Pharmacology Indian Medical PG Practice Questions and MCQs

Question 161: For which of the following schedules is a warning written 'To be sold by retail on the prescription of a Registered Medical Practitioner only'?

A. Schedule H (Correct Answer)
B. Schedule X
C. Schedule Y
D. Schedule J

Explanation: ### Explanation **Correct Option: A (Schedule H)** Schedule H drugs are defined under the Drugs and Cosmetics Rules, 1945, as "Prescription Drugs." These substances cannot be purchased over the counter (OTC) and must bear the specific mandatory warning: **"To be sold by retail on the prescription of a Registered Medical Practitioner only."** This regulation ensures that potent medications (like most antibiotics, hormones, and antihypertensives) are used only under medical supervision to prevent misuse and drug resistance. **Analysis of Incorrect Options:** * **Schedule X:** These are Narcotic and Psychotropic substances (e.g., Ketamine, Amphetamines). They require a more stringent warning: **"Schedule X drug - Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only."** They also require the pharmacist to maintain a duplicate copy of the prescription for two years. * **Schedule Y:** This schedule details the requirements and guidelines for **Clinical Trials** for the import and manufacture of new drugs. It is not related to retail labeling warnings. * **Schedule J:** This contains a list of diseases and ailments (e.g., AIDS, Blindness, Cancer) which a drug **may not purport to prevent or cure**. It prohibits manufacturers from making false claims regarding these conditions. **High-Yield Clinical Pearls for NEET-PG:** * **Schedule H1:** A sub-category introduced to control the use of 3rd/4th gen antibiotics and anti-TB drugs. It carries a warning in **Red Box** and requires a separate register for sales. * **Schedule G:** Drugs to be taken under **medical supervision** (e.g., Metformin, Antihistamines). Label warning: "Caution: It is dangerous to take this preparation except under medical supervision." * **Schedule K:** Contains a list of drugs **exempted** from certain provisions of manufacture/sale.

Question 162: Ebstein anomaly is caused by the usage of which drug during pregnancy?

A. Phenytoin
B. Lithium (Correct Answer)
C. Warfarin
D. Enalapril

Explanation: **Explanation:** **Lithium (Correct Answer):** Lithium is a mood stabilizer used for Bipolar Disorder. When administered during the first trimester of pregnancy, it acts as a teratogen, specifically affecting cardiac development. It is classically associated with **Ebstein’s Anomaly**, a congenital heart defect characterized by the "atrialization" of the right ventricle due to the downward displacement of the tricuspid valve leaflets. This leads to a small functional right ventricle and severe tricuspid regurgitation. **Analysis of Incorrect Options:** * **Phenytoin:** This anticonvulsant causes **Fetal Hydantoin Syndrome**, characterized by craniofacial dysmorphism (cleft lip/palate), hypoplastic phalanges, and nail hypoplasia. * **Warfarin:** Exposure during the first trimester leads to **Fetal Warfarin Syndrome**, presenting with nasal hypoplasia, depressed nasal bridge, and stippled epiphyses (chondrodysplasia punctata). * **Enalapril (ACE Inhibitor):** These are contraindicated in the 2nd and 3rd trimesters. They cause **fetal renal dysgenesis**, leading to oligohydramnios, which results in pulmonary hypoplasia and skull ossification defects (Potter sequence). **High-Yield Clinical Pearls for NEET-PG:** * **Absolute Risk:** While the *relative risk* of Ebstein anomaly is high with Lithium, the *absolute risk* remains low (approx. 1 in 1,000 to 2,000). * **Management:** If a pregnant woman is stable on Lithium, it is often continued with close fetal echocardiography monitoring, as the risk of bipolar relapse often outweighs the teratogenic risk. * **Other Cardiac Teratogens:** Alcohol (VSD/ASD), Isotretinoin (Transposition of Great Arteries).

Question 163: Drug distribution is inversely proportional to which of the following?

A. Plasma protein binding (Correct Answer)
B. Lipid solubility
C. Fat layer in the body
D. Structure of the drug

Explanation: ### Explanation **Drug distribution** refers to the reversible transfer of a drug from the systemic circulation to the tissues. The relationship between drug distribution and plasma protein binding is a fundamental concept in pharmacokinetics. **Why Plasma Protein Binding is the Correct Answer:** Drugs in the blood exist in two forms: bound to plasma proteins (like albumin or $\alpha_1$-acid glycoprotein) and free (unbound). Only the **free fraction** is small enough to cross capillary membranes and distribute into tissues. When a drug has high plasma protein binding, it is effectively "trapped" within the vascular compartment. Therefore, as plasma protein binding increases, the volume of distribution ($V_d$) decreases. This establishes an **inverse relationship**. **Analysis of Incorrect Options:** * **B. Lipid solubility:** Distribution is **directly proportional** to lipid solubility. Highly lipid-soluble drugs (e.g., Thiopental) easily cross biological membranes (including the blood-brain barrier), leading to extensive tissue distribution. * **C. Fat layer in the body:** This is also **directly proportional**. Lipophilic drugs sequester in adipose tissue. Patients with a higher body fat percentage will have a larger $V_d$ for lipid-soluble drugs. * **D. Structure of the drug:** While the chemical structure (molecular weight, ionization state) influences distribution, it is not a "proportional" relationship in mathematical terms. It is a qualitative determinant rather than a quantitative inverse correlation. **High-Yield Clinical Pearls for NEET-PG:** * **Volume of Distribution ($V_d$):** Defined as $V_d = \text{Total amount of drug in body} / \text{Plasma concentration}$. * **Acidic drugs** (e.g., Warfarin, NSAIDs) primarily bind to **Albumin**. * **Basic drugs** (e.g., Lidocaine, Propranolol) primarily bind to **$\alpha_1$-acid glycoprotein**. * **Displacement Interactions:** Drugs with high protein binding (e.g., Sulfonamides) can displace other drugs (e.g., Bilirubin in neonates, leading to Kernicterus). * **Hemodialysis:** Drugs with a high $V_d$ (extensive tissue binding) cannot be removed effectively by dialysis.

Question 164: What are the undesirable but unavoidable pharmacodynamic effects of a drug known as?

A. Toxic effects
B. Idiosyncrasy
C. Side effects (Correct Answer)
D. Intolerance

Explanation: ### Explanation **Correct Answer: C. Side effects** **Why it is correct:** Side effects are defined as **undesirable but unavoidable** pharmacodynamic effects that occur at **therapeutic doses**. They are an extension of the drug's pharmacological action. For example, dry mouth is a side effect of Atropine because the drug’s mechanism (muscarinic blockade) inherently affects salivary secretions while treating bradycardia. Because these effects are based on the drug's primary or secondary pharmacological profile, they are predictable and seen in a significant proportion of the population. **Why the other options are incorrect:** * **A. Toxic effects:** These are serious, harmful effects resulting from **excessive dosage** or prolonged use (overdosage). Unlike side effects, they are not expected at standard therapeutic levels. * **B. Idiosyncrasy:** This refers to a **genetically determined abnormal reaction** to a drug that is unique to an individual (e.g., hemolysis in G6PD deficient patients treated with Primaquine). It is unpredictable and not related to the drug's known pharmacological action. * **C. Intolerance:** This is a low threshold for the normal pharmacological action of a drug. The individual experiences characteristic side effects even at **sub-therapeutic or very low doses** (e.g., a single dose of Trinitroglycerin causing a severe headache in some patients). **High-Yield Clinical Pearls for NEET-PG:** * **Side Effect vs. Adverse Effect:** While often used interchangeably, an "Adverse Effect" is a broader term for any unintended/harmful occurrence, whereas a "Side Effect" specifically relates to the drug's known pharmacology. * **Secondary Effects:** These are indirect consequences of a drug's primary action (e.g., Vitamin B deficiency or diarrhea caused by broad-spectrum antibiotics altering gut flora). * **Type A vs. Type B Reactions:** Side effects are **Type A (Augmented)** reactions (predictable, dose-dependent), while Idiosyncrasy and Allergies are **Type B (Bizarre)** reactions (unpredictable, dose-independent).

Question 165: Which drug is recommended for chemoprophylaxis one day before induction into high altitude areas?

A. Acetazolamide (Correct Answer)
B. Furosemide
C. Doxycycline
D. Paracetamol

Explanation: **Explanation:** **Acetazolamide** is the drug of choice for the prevention of **Acute Mountain Sickness (AMS)**. It is a carbonic anhydrase inhibitor that works by inhibiting the enzyme in the proximal convoluted tubule of the kidney. This leads to bicarbonate diuresis, resulting in a mild **metabolic acidosis**. To compensate for this acidosis, the body increases the respiratory rate (hyperventilation), which improves oxygenation and accelerates the natural process of acclimatization. For effective prophylaxis, it is recommended to start the drug 24 hours before ascent. **Analysis of Incorrect Options:** * **Furosemide (Option B):** While it is a potent loop diuretic, it is used in the *treatment* of High-Altitude Pulmonary Edema (HAPE) to reduce fluid in the lungs, but it is not used for routine prophylaxis of AMS. * **Doxycycline (Option C):** This is an antibiotic used for chemoprophylaxis against Malaria or Leptospirosis, having no role in high-altitude illness. * **Paracetamol (Option D):** This is an analgesic used to treat the headache associated with altitude sickness but does not prevent the underlying physiological cause or aid in acclimatization. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Induces metabolic acidosis → stimulates chemoreceptors → increases minute ventilation. * **Side Effects:** Common side effects include **paresthesia** (tingling in fingers/toes) and a **metallic taste** when consuming carbonated beverages. * **Contraindication:** Avoid in patients with a known **Sulfa allergy**. * **Treatment of Choice:** For established HAPE, the drug of choice is **Nifedipine**; for High-Altitude Cerebral Edema (HACE), it is **Dexamethasone**.

Question 166: Which drug is used for the management of obesity?

A. Orlistat (Correct Answer)
B. Rivastigmine
C. Nitrous oxide
D. Phenylephrine

Explanation: **Explanation:** **Correct Option: A. Orlistat** Orlistat is a potent, specific, and long-acting **inhibitor of gastric and pancreatic lipases**. Its mechanism of action involves forming a covalent bond with the active serine site of these enzymes in the lumen of the stomach and small intestine. This prevents the hydrolysis of dietary fat (triglycerides) into absorbable free fatty acids and monoglycerides. Consequently, approximately 30% of dietary fat remains unabsorbed and is excreted in the feces, leading to a caloric deficit and weight loss. **Incorrect Options:** * **B. Rivastigmine:** A pseudo-irreversible acetylcholinesterase inhibitor used primarily in the management of **Alzheimer’s disease** and Parkinson’s dementia. * **C. Nitrous oxide:** An inhalational anesthetic gas (Laughing gas) used for **general anesthesia** and analgesia. * **D. Phenylephrine:** A selective **$\alpha_1$-adrenergic agonist** used as a nasal decongestant and a pressor agent to treat hypotension. **Clinical Pearls for NEET-PG:** * **Side Effects of Orlistat:** Due to fat malabsorption, it commonly causes **steatorrhea** (oily spotting), flatus with discharge, and fecal urgency. It can also interfere with the absorption of **fat-soluble vitamins (A, D, E, K)**; supplementation is often required. * **Other FDA-approved drugs for Obesity:** * **Liraglutide/Semaglutide:** GLP-1 receptor agonists (injectable). * **Phentermine/Topiramate:** Combination therapy (sympathomimetic + antiepileptic). * **Naltrexone/Bupropion:** Combination targeting reward pathways. * **Lorcaserin:** 5-HT$_{2C}$ agonist (withdrawn in many regions due to cancer risk).

Question 167: A bolus of drug K is given intravenously. The drug is noted to follow first-order kinetics. Which of the following describes the elimination of drug K?

A. The rate of elimination of drug K is proportional to its concentration in the patient's plasma. (Correct Answer)
B. The rate of elimination of drug K is dependent on a nonlinear relationship to the plasma protein concentration.
C. The rate of elimination of drug K is constant.
D. The rate of elimination of drug K is proportional to the patient's renal function.

Explanation: ### Explanation **1. Why Option A is Correct:** The core characteristic of **First-Order Kinetics** (also known as linear kinetics) is that the **rate of elimination is directly proportional to the plasma concentration** of the drug. In this model, a constant *fraction* (percentage) of the drug is eliminated per unit of time. Mathematically, this is represented as: *Rate of elimination = CL × C* (where CL is clearance and C is plasma concentration). Since most drugs at therapeutic doses do not saturate their elimination pathways (enzymes/transporters), they follow first-order kinetics. **2. Why Other Options are Incorrect:** * **Option B:** While plasma protein binding affects the volume of distribution and the fraction of drug available for elimination, first-order kinetics is defined by a linear relationship with plasma concentration, not a nonlinear relationship with protein concentration. * **Option C:** This describes **Zero-Order Kinetics** (e.g., Ethanol, Phenytoin, Aspirin at high doses). In zero-order kinetics, a constant *amount* of drug is eliminated per unit of time regardless of concentration because the elimination mechanisms are saturated. * **Option D:** While renal function (GFR) influences the *clearance* of drugs excreted by the kidney, the definition of first-order kinetics specifically refers to the relationship between the elimination rate and the drug's own plasma concentration. **3. NEET-PG High-Yield Pearls:** * **First-Order:** Constant **fraction** eliminated; Half-life ($t_{1/2}$) is **constant**; Most drugs follow this. * **Zero-Order:** Constant **amount** eliminated; Half-life ($t_{1/2}$) is **variable** (decreases as concentration decreases); Also called "Saturable" or "Non-linear" kinetics. * **Steady State:** In first-order kinetics, it takes approximately **4 to 5 half-lives** to reach a steady-state concentration. * **Mixed Order (Michaelis-Menten):** Some drugs shift from zero-order to first-order as their plasma concentration falls below the saturation point of metabolic enzymes.

Question 168: Who discovered that nerve terminals release chemicals?

A. Dale
B. Withering
C. Domagk
D. Loewi (Correct Answer)

Explanation: **Explanation:** The correct answer is **Otto Loewi (D)**. In 1921, Loewi conducted a landmark experiment using two frog hearts. He stimulated the vagus nerve of the first heart, causing it to slow down, and then transferred the surrounding fluid to a second heart. The second heart slowed down as well, proving that the nerve did not act electrically but released a chemical substance (which he called *Vagusstoff*, later identified as Acetylcholine). This discovery earned him the Nobel Prize and established the concept of **chemical neurotransmission**. **Analysis of Incorrect Options:** * **A. Dale (Sir Henry Dale):** While he worked closely with Loewi and identified Acetylcholine as a neurotransmitter, he is best known for **Dale’s Principle** (the theory that a neuron releases the same neurotransmitter at all its synapses) and for isolating histamine. * **B. Withering (William Withering):** An English physician famous for discovering the clinical use of **Digitalis** (Foxglove) in the treatment of dropsy (heart failure) in 1785. * **C. Domagk (Gerhard Domagk):** A pathologist credited with the discovery of **Prontosil**, the first commercially available sulfonamide (antibacterial), which ushered in the era of modern antibiotics. **High-Yield NEET-PG Pearls:** * **Father of Pharmacology:** Oswald Schmiedeberg. * **Father of Chemotherapy:** Paul Ehrlich (also coined the term "Magic Bullet"). * **Father of Indian Pharmacology:** Ram Nath Chopra. * **Loewi’s Experiment:** Proved chemical transmission; the substance was **Acetylcholine**, the first neurotransmitter to be discovered.

Question 169: Sildenafil (Viagra) produces its physiological effects by blocking the enzyme that hydrolyzes the second messenger by which nitric oxide produces its physiological effects. What is this second messenger?

A. Bradykinin
B. Cyclic GMP (Correct Answer)
C. Protein kinase A
D. Endothelin

Explanation: **Explanation:** **Mechanism of Action:** Nitric Oxide (NO) is a potent vasodilator released from vascular endothelial cells. It activates the enzyme **Guanylate Cyclase**, which converts GTP into **Cyclic GMP (cGMP)**. cGMP acts as the **second messenger** that triggers protein kinase G, leading to smooth muscle relaxation and increased blood flow (vasodilation). In the corpus cavernosum, this process results in penile erection. Sildenafil is a selective inhibitor of **Phosphodiesterase-5 (PDE-5)**, the enzyme responsible for the hydrolysis (breakdown) of cGMP. By blocking PDE-5, Sildenafil prevents the degradation of cGMP, prolonging its vasodilatory effects. **Analysis of Incorrect Options:** * **A. Bradykinin:** This is a potent vasodilator peptide, not a second messenger. It works by stimulating the release of NO and prostacyclin. * **C. Protein kinase A:** This is the downstream effector for the **cAMP** pathway (e.g., stimulated by Beta-agonists), not the cGMP pathway. * **D. Endothelin:** This is a potent endogenous **vasoconstrictor** peptide, acting in opposition to the effects of Nitric Oxide. **High-Yield NEET-PG Pearls:** * **Drug Interaction:** Sildenafil is strictly contraindicated with **Nitrates** (e.g., Nitroglycerin) because both increase cGMP through different mechanisms, leading to synergistic peripheral vasodilation and life-threatening hypotension. * **Other PDE-5 Inhibitors:** Tadalafil (longer half-life, "the weekend pill") and Vardenafil. * **Other Indications:** PDE-5 inhibitors are also used in the management of **Pulmonary Arterial Hypertension (PAH)**. * **Side Effect:** "Blue vision" (cyanopsia) occurs due to weak inhibition of PDE-6 in the retina.

Question 170: Which of the following acts as an inverse agonist?

A. Buspirone
B. b-carboline (Correct Answer)
C. Flumazenil
D. Zolpidem

Explanation: ### Explanation **Concept of Inverse Agonists** An **inverse agonist** is a ligand that binds to the same receptor site as an agonist but produces a pharmacological response **opposite** to that of the agonist. This occurs because inverse agonists reduce the constitutive (basal) activity of receptors that are active even in the absence of a ligand. **Why B-carboline is Correct** The GABA-A receptor is a chloride channel. While GABA (agonist) and Benzodiazepines (facilitatory modulators) increase chloride influx leading to CNS depression/sedation, **$\beta$-carbolines** act as **inverse agonists** at the Benzodiazepine (BZD) site. They decrease chloride conductance, resulting in effects opposite to BZDs—namely **anxiety, restlessness, and convulsions**. **Analysis of Incorrect Options** * **A. Buspirone:** It is a **selective 5-HT1A partial agonist** used as an anxiolytic. It does not act on the GABA-BZD receptor complex. * **C. Flumazenil:** It is a **competitive antagonist** at the BZD receptor. It has no intrinsic activity of its own; it simply blocks the effects of both agonists (BZDs) and inverse agonists ($\beta$-carbolines). * **D. Zolpidem:** It is a **non-benzodiazepine hypnotic** that acts as a **full agonist** at the $\alpha_1$ subunit of the GABA-A receptor. **High-Yield Clinical Pearls for NEET-PG** * **Inverse Agonist Examples:** $\beta$-carboline (GABA-A), Naloxone (at $\mu$ receptors—though traditionally called an antagonist, it shows inverse agonism), and Famotidine (H2 receptors). * **Flumazenil** is the drug of choice for BZD overdose but can precipitate seizures in BZD-dependent patients. * **Constitutive Activity:** The ability of a receptor to show a response without any ligand; inverse agonists are only effective against receptors showing this property.

Practice by Chapter

Pharmacokinetics: Absorption and Distribution

Practice Questions

Pharmacokinetics: Metabolism and Excretion

Practice Questions

Pharmacodynamics and Receptor Theory

Practice Questions

Drug-Receptor Interactions and Dose-Response

Practice Questions

Pharmacogenetics and Personalized Medicine

Practice Questions

Adverse Drug Reactions and Toxicity

Practice Questions

Drug Interactions

Practice Questions

Drug Development and Regulation

Practice Questions

Pediatric and Geriatric Pharmacology

Practice Questions

Placental Transfer and Lactation

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free